Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

Measuring risk of HIV and HCV among injecting drug users in the Russian Federation

Tools
- Tools
+ Tools

Platt, Lucy, Sutton, A. J., Vickerman, P., Koshkina, E., Maximova, S., Latishevskaya, N., Hickman, M., Bonell, C., Parry, J. and Rhodes, T. (2009) Measuring risk of HIV and HCV among injecting drug users in the Russian Federation. European Journal of Public Health, Vol.19 (No.4). pp. 428-433. doi:10.1093/eurpub/ckp041 ISSN 1101-1262.

Research output not available from this repository.

Request-a-Copy directly from author or use local Library Get it For Me service.

Official URL: http://dx.doi.org/10.1093/eurpub/ckp041

Request Changes to record.

Abstract

Background: The aim of the study was to measure risk of HIV and HCV infection among injecting drug users (IDUs) through force of infection (FOI) models in three cities of the Russian Federation and assess the value of behavioural data and FOI in predicting risk of infection as a method of second-generation surveillance. Methods: FOI models were fitted to prevalence data collected through an anonymous, cross-sectional community-recruited survey of IDUs with oral fluid sample collection for antibodies to HIV and HCV. Risk of infection was estimated from FOI estimates obtained by fitting a model to prevalence data by length of injecting career for each city and then overall. Risk behaviours were examined by injecting career length. Results: A total of 1473 IDUs were recruited. Prevalence of HIV was 8.1% (95% CI 6.79.6%) and HCV 63.4% (95% CI 60.965.9%). A higher FOI in new initiates to injecting (injecting career length < 1 year) was found for both HIV and HCV compared with experienced IDUs (injecting career length < 5 years). Increased risk of infection was not corroborated by injecting risk behaviours among new initiates into injecting (n38). Only 5.7% (n2) reported receptive sharing in the last 4 weeks, 57.9% (n22) sharing any injecting paraphernalia, 2.6% (n1) frontloading and 8.5% (n3) ever injecting with used needles/syringes. However, 29% of new initiates reported exchanging sex in the last 4 weeks (29%) compared with 11% long term IDUs. Conclusions: FOI models can play an important role in surveillance of HIV but caution is needed in the interpretation of behavioural data for predicting current or future risk of HIV.

Item Type: Journal Article
Subjects: R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine
Divisions: Faculty of Science, Engineering and Medicine > Science > Life Sciences (2010- ) > Biological Sciences ( -2010)
Journal or Publication Title: European Journal of Public Health
Publisher: Oxford University Press
ISSN: 1101-1262
Official Date: August 2009
Dates:
DateEvent
August 2009Published
Volume: Vol.19
Number: No.4
Number of Pages: 6
Page Range: pp. 428-433
DOI: 10.1093/eurpub/ckp041
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Restricted or Subscription Access
Funder: UK Department for International Development, UK Department of Health

Data sourced from Thomson Reuters' Web of Knowledge

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item
twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us